 Edward Melanson
Concepts (323)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Energy Metabolism | 44 | 2022 | 762 | 6.330 |
Why?
| | Exercise | 36 | 2022 | 1647 | 3.940 |
Why?
| | Weight Loss | 22 | 2022 | 652 | 3.270 |
Why?
| | Energy Intake | 27 | 2022 | 445 | 2.720 |
Why?
| | Thermogenesis | 5 | 2020 | 43 | 1.940 |
Why?
| | Calorimetry, Indirect | 15 | 2021 | 72 | 1.890 |
Why?
| | Calorimetry | 9 | 2021 | 59 | 1.510 |
Why?
| | Breakfast | 2 | 2020 | 17 | 1.500 |
Why?
| | Sleep | 14 | 2022 | 651 | 1.450 |
Why?
| | Eating | 12 | 2022 | 366 | 1.440 |
Why?
| | Obesity | 24 | 2023 | 2715 | 1.430 |
Why?
| | Meals | 5 | 2020 | 101 | 1.420 |
Why?
| | Dietary Fats | 7 | 2019 | 323 | 1.360 |
Why?
| | Caloric Restriction | 5 | 2022 | 91 | 1.140 |
Why?
| | Overweight | 9 | 2022 | 492 | 1.140 |
Why?
| | Oxygen Consumption | 11 | 2018 | 585 | 1.080 |
Why?
| | Fasting | 6 | 2022 | 256 | 1.060 |
Why?
| | Weight Reduction Programs | 3 | 2021 | 93 | 1.020 |
Why?
| | Body Composition | 16 | 2024 | 644 | 0.950 |
Why?
| | Premenopause | 3 | 2020 | 107 | 0.950 |
Why?
| | Estradiol | 2 | 2018 | 473 | 0.940 |
Why?
| | Behavior Therapy | 3 | 2021 | 236 | 0.940 |
Why?
| | Diet | 8 | 2023 | 1143 | 0.920 |
Why?
| | Lipid Metabolism | 5 | 2012 | 473 | 0.890 |
Why?
| | Oxygen Isotopes | 3 | 2021 | 16 | 0.870 |
Why?
| | Monitoring, Physiologic | 5 | 2017 | 268 | 0.840 |
Why?
| | Dietary Carbohydrates | 8 | 2019 | 157 | 0.840 |
Why?
| | Resistance Training | 4 | 2021 | 120 | 0.840 |
Why?
| | Dietary Proteins | 7 | 2019 | 131 | 0.830 |
Why?
| | Body Weight | 11 | 2021 | 923 | 0.810 |
Why?
| | Sleep Deprivation | 9 | 2021 | 164 | 0.800 |
Why?
| | Water | 3 | 2021 | 422 | 0.790 |
Why?
| | Basal Metabolism | 7 | 2021 | 50 | 0.780 |
Why?
| | Ovary | 3 | 2020 | 205 | 0.780 |
Why?
| | Gonadotropin-Releasing Hormone | 3 | 2018 | 193 | 0.740 |
Why?
| | Reference Standards | 1 | 2020 | 174 | 0.730 |
Why?
| | Weight Gain | 10 | 2024 | 485 | 0.710 |
Why?
| | Adult | 57 | 2023 | 31325 | 0.690 |
Why?
| | Time Factors | 20 | 2021 | 6368 | 0.680 |
Why?
| | Adipose Tissue, Brown | 2 | 2019 | 71 | 0.670 |
Why?
| | Humans | 98 | 2024 | 118257 | 0.660 |
Why?
| | Exercise Test | 9 | 2024 | 552 | 0.660 |
Why?
| | Adipose Tissue, White | 1 | 2018 | 35 | 0.650 |
Why?
| | Pulmonary Gas Exchange | 2 | 2018 | 117 | 0.650 |
Why?
| | Circadian Rhythm | 10 | 2020 | 394 | 0.620 |
Why?
| | Female | 68 | 2024 | 61262 | 0.620 |
Why?
| | Cancer Survivors | 1 | 2021 | 201 | 0.610 |
Why?
| | Sleep Initiation and Maintenance Disorders | 1 | 2019 | 118 | 0.610 |
Why?
| | Isotope Labeling | 1 | 2017 | 75 | 0.600 |
Why?
| | Body Mass Index | 17 | 2022 | 2074 | 0.570 |
Why?
| | Walking | 6 | 2021 | 415 | 0.560 |
Why?
| | Middle Aged | 34 | 2023 | 27511 | 0.550 |
Why?
| | Male | 67 | 2024 | 57476 | 0.550 |
Why?
| | Rest | 4 | 2018 | 104 | 0.540 |
Why?
| | Estrogens | 1 | 2018 | 329 | 0.540 |
Why?
| | Leuprolide | 1 | 2015 | 20 | 0.530 |
Why?
| | Muscle, Skeletal | 5 | 2014 | 1515 | 0.520 |
Why?
| | Hunger | 2 | 2021 | 46 | 0.490 |
Why?
| | Mass Spectrometry | 1 | 2017 | 670 | 0.480 |
Why?
| | Oxidation-Reduction | 9 | 2019 | 935 | 0.460 |
Why?
| | Cross-Over Studies | 8 | 2021 | 456 | 0.450 |
Why?
| | Young Adult | 20 | 2021 | 10731 | 0.450 |
Why?
| | Exercise Tolerance | 2 | 2018 | 234 | 0.450 |
Why?
| | Fatty Acids | 3 | 2012 | 403 | 0.440 |
Why?
| | Monitoring, Ambulatory | 4 | 2017 | 84 | 0.430 |
Why?
| | Temperature | 1 | 2014 | 621 | 0.410 |
Why?
| | Appetite Regulation | 3 | 2021 | 26 | 0.410 |
Why?
| | Deglutition | 5 | 2014 | 62 | 0.400 |
Why?
| | Thinness | 1 | 2012 | 91 | 0.400 |
Why?
| | Physical Exertion | 4 | 2018 | 221 | 0.400 |
Why?
| | Activities of Daily Living | 4 | 2018 | 353 | 0.390 |
Why?
| | Perception | 1 | 2013 | 314 | 0.370 |
Why?
| | Breast Neoplasms | 1 | 2021 | 1957 | 0.350 |
Why?
| | Work Schedule Tolerance | 3 | 2020 | 36 | 0.350 |
Why?
| | Fats | 1 | 2009 | 13 | 0.350 |
Why?
| | Body Weight Maintenance | 2 | 2019 | 15 | 0.340 |
Why?
| | Adaptation, Psychological | 1 | 2013 | 545 | 0.340 |
Why?
| | Appetite | 3 | 2021 | 56 | 0.330 |
Why?
| | Lipid Peroxidation | 1 | 2009 | 156 | 0.330 |
Why?
| | Posture | 5 | 2016 | 158 | 0.330 |
Why?
| | Carbon Dioxide | 1 | 2010 | 230 | 0.320 |
Why?
| | Reproducibility of Results | 12 | 2023 | 2855 | 0.310 |
Why?
| | Heart Rate | 5 | 2024 | 729 | 0.310 |
Why?
| | Menopause | 2 | 2022 | 266 | 0.300 |
Why?
| | Anorexia Nervosa | 2 | 2005 | 74 | 0.300 |
Why?
| | Parkinson Disease | 2 | 2024 | 334 | 0.290 |
Why?
| | Wakefulness | 5 | 2020 | 128 | 0.290 |
Why?
| | Cold Temperature | 2 | 2019 | 130 | 0.280 |
Why?
| | Shoes | 5 | 2017 | 21 | 0.270 |
Why?
| | Gastrointestinal Microbiome | 2 | 2023 | 538 | 0.270 |
Why?
| | Calcium, Dietary | 1 | 2005 | 55 | 0.270 |
Why?
| | Metabolic Syndrome | 1 | 2009 | 392 | 0.260 |
Why?
| | Mastication | 4 | 2014 | 14 | 0.250 |
Why?
| | Sports Equipment | 1 | 2004 | 6 | 0.250 |
Why?
| | Double-Blind Method | 3 | 2019 | 1683 | 0.250 |
Why?
| | Deuterium | 3 | 2021 | 78 | 0.240 |
Why?
| | Signal Processing, Computer-Assisted | 3 | 2017 | 140 | 0.240 |
Why?
| | Autonomic Nervous System Diseases | 1 | 2024 | 28 | 0.240 |
Why?
| | HIV Integrase | 1 | 2024 | 66 | 0.220 |
Why?
| | HIV Integrase Inhibitors | 1 | 2024 | 60 | 0.220 |
Why?
| | Motor Activity | 3 | 2019 | 664 | 0.220 |
Why?
| | Puberty | 2 | 2014 | 143 | 0.210 |
Why?
| | Insulin Resistance | 4 | 2019 | 1167 | 0.210 |
Why?
| | Circadian Clocks | 2 | 2019 | 46 | 0.210 |
Why?
| | Bone Density | 2 | 2015 | 447 | 0.200 |
Why?
| | Accelerometry | 3 | 2021 | 72 | 0.200 |
Why?
| | Aging | 2 | 2012 | 1675 | 0.200 |
Why?
| | Diet, Fat-Restricted | 3 | 2011 | 76 | 0.200 |
Why?
| | France | 1 | 2021 | 35 | 0.200 |
Why?
| | Diabetes Mellitus | 1 | 2009 | 939 | 0.200 |
Why?
| | Feeding Behavior | 4 | 2011 | 595 | 0.200 |
Why?
| | Adolescent | 13 | 2021 | 18364 | 0.200 |
Why?
| | Spectrum Analysis | 2 | 2019 | 88 | 0.190 |
Why?
| | Bone Remodeling | 1 | 2021 | 64 | 0.190 |
Why?
| | Analysis of Variance | 6 | 2021 | 1288 | 0.190 |
Why?
| | Fruit | 1 | 2021 | 129 | 0.190 |
Why?
| | Vegetables | 1 | 2021 | 132 | 0.190 |
Why?
| | Cardiovascular Diseases | 2 | 2022 | 1795 | 0.190 |
Why?
| | Nitrogen | 2 | 2012 | 154 | 0.180 |
Why?
| | Amputees | 1 | 2021 | 62 | 0.180 |
Why?
| | Sweating | 1 | 2019 | 24 | 0.180 |
Why?
| | Nutritive Value | 1 | 2019 | 29 | 0.180 |
Why?
| | Inpatients | 1 | 2023 | 387 | 0.180 |
Why?
| | Starch | 1 | 2019 | 24 | 0.180 |
Why?
| | Contraceptive Agents | 1 | 2020 | 56 | 0.180 |
Why?
| | Cardiorespiratory Fitness | 1 | 2019 | 39 | 0.170 |
Why?
| | Parathyroid Hormone | 1 | 2019 | 99 | 0.170 |
Why?
| | Adipocytes | 2 | 2018 | 195 | 0.170 |
Why?
| | Body Temperature | 2 | 2010 | 214 | 0.170 |
Why?
| | Telerehabilitation | 1 | 2019 | 26 | 0.170 |
Why?
| | Artificial Limbs | 1 | 2021 | 116 | 0.160 |
Why?
| | Hospitals | 1 | 2023 | 600 | 0.160 |
Why?
| | Proof of Concept Study | 1 | 2018 | 46 | 0.160 |
Why?
| | Time-to-Treatment | 1 | 2019 | 148 | 0.160 |
Why?
| | Postprandial Period | 3 | 2020 | 96 | 0.160 |
Why?
| | Adaptation, Physiological | 3 | 2018 | 501 | 0.160 |
Why?
| | Pilot Projects | 5 | 2022 | 1405 | 0.160 |
Why?
| | Cross-Sectional Studies | 5 | 2021 | 4522 | 0.160 |
Why?
| | High-Intensity Interval Training | 1 | 2018 | 18 | 0.160 |
Why?
| | Guideline Adherence | 1 | 2022 | 520 | 0.150 |
Why?
| | Self Report | 1 | 2021 | 698 | 0.150 |
Why?
| | Postmenopause | 1 | 2019 | 305 | 0.150 |
Why?
| | Algorithms | 4 | 2015 | 1522 | 0.150 |
Why?
| | Wearable Electronic Devices | 1 | 2017 | 34 | 0.150 |
Why?
| | Brain Mapping | 3 | 2016 | 530 | 0.150 |
Why?
| | Gait | 2 | 2017 | 253 | 0.150 |
Why?
| | Computer Storage Devices | 1 | 2016 | 2 | 0.150 |
Why?
| | Tachycardia, Ventricular | 1 | 2018 | 151 | 0.150 |
Why?
| | Melatonin | 4 | 2020 | 104 | 0.140 |
Why?
| | Odds Ratio | 1 | 2019 | 993 | 0.140 |
Why?
| | Combined Modality Therapy | 1 | 2019 | 1163 | 0.140 |
Why?
| | Needs Assessment | 1 | 2018 | 325 | 0.140 |
Why?
| | Homeostasis | 3 | 2019 | 589 | 0.140 |
Why?
| | Life Style | 2 | 2021 | 431 | 0.140 |
Why?
| | Microbiota | 1 | 2023 | 655 | 0.140 |
Why?
| | Estrogens, Conjugated (USP) | 1 | 2015 | 34 | 0.130 |
Why?
| | Ghrelin | 3 | 2021 | 30 | 0.130 |
Why?
| | Blood Glucose | 4 | 2020 | 1936 | 0.130 |
Why?
| | Metabolomics | 1 | 2020 | 540 | 0.130 |
Why?
| | Defibrillators, Implantable | 1 | 2018 | 299 | 0.130 |
Why?
| | Arthroplasty, Replacement, Knee | 1 | 2019 | 247 | 0.130 |
Why?
| | Skin | 1 | 2019 | 657 | 0.130 |
Why?
| | Sleep Stages | 1 | 2014 | 60 | 0.130 |
Why?
| | Triglycerides | 2 | 2019 | 515 | 0.120 |
Why?
| | Proteome | 1 | 2018 | 349 | 0.120 |
Why?
| | Brain | 3 | 2016 | 2481 | 0.120 |
Why?
| | Health Status | 1 | 2019 | 723 | 0.120 |
Why?
| | Exercise Therapy | 1 | 2018 | 355 | 0.120 |
Why?
| | Diet Records | 2 | 2014 | 80 | 0.120 |
Why?
| | Biomarkers | 4 | 2021 | 3568 | 0.120 |
Why?
| | Calcium | 1 | 2019 | 1151 | 0.110 |
Why?
| | Aged | 10 | 2021 | 19594 | 0.110 |
Why?
| | Insulin | 5 | 2020 | 2157 | 0.110 |
Why?
| | Muscle Fatigue | 1 | 2014 | 91 | 0.110 |
Why?
| | Task Performance and Analysis | 1 | 2014 | 164 | 0.110 |
Why?
| | Food | 2 | 2011 | 162 | 0.110 |
Why?
| | Nervous System Physiological Phenomena | 1 | 2013 | 22 | 0.110 |
Why?
| | Cell Phone | 1 | 2014 | 80 | 0.110 |
Why?
| | Sound Spectrography | 2 | 2009 | 24 | 0.110 |
Why?
| | Blood Pressure | 1 | 2019 | 1656 | 0.110 |
Why?
| | Hot Temperature | 2 | 2018 | 333 | 0.110 |
Why?
| | Area Under Curve | 1 | 2013 | 293 | 0.110 |
Why?
| | Aged, 80 and over | 5 | 2021 | 6541 | 0.100 |
Why?
| | Adipose Tissue | 3 | 2011 | 595 | 0.100 |
Why?
| | Smoking | 1 | 2019 | 1478 | 0.100 |
Why?
| | Case-Control Studies | 4 | 2021 | 3156 | 0.100 |
Why?
| | Sex Factors | 2 | 2014 | 1765 | 0.100 |
Why?
| | Physical Fitness | 1 | 2013 | 179 | 0.100 |
Why?
| | Nerve Net | 1 | 2013 | 232 | 0.100 |
Why?
| | Heart Failure | 1 | 2024 | 1967 | 0.100 |
Why?
| | Physical Phenomena | 1 | 2010 | 12 | 0.090 |
Why?
| | Muscle Proteins | 1 | 2012 | 218 | 0.090 |
Why?
| | Collagen Type I | 2 | 2021 | 114 | 0.090 |
Why?
| | Diet Surveys | 1 | 2009 | 84 | 0.090 |
Why?
| | HIV Infections | 1 | 2024 | 2454 | 0.090 |
Why?
| | Somatotypes | 1 | 2009 | 5 | 0.090 |
Why?
| | Spirometry | 1 | 2010 | 262 | 0.090 |
Why?
| | Cues | 1 | 2011 | 297 | 0.090 |
Why?
| | Glycerol | 1 | 2009 | 87 | 0.090 |
Why?
| | Pattern Recognition, Automated | 1 | 2009 | 75 | 0.090 |
Why?
| | Thermography | 1 | 2009 | 12 | 0.090 |
Why?
| | Validation Studies as Topic | 1 | 2009 | 21 | 0.090 |
Why?
| | Models, Biological | 3 | 2018 | 1701 | 0.080 |
Why?
| | Weight Lifting | 1 | 2009 | 30 | 0.080 |
Why?
| | Peptide YY | 2 | 2021 | 10 | 0.080 |
Why?
| | Diet, Reducing | 2 | 2021 | 83 | 0.080 |
Why?
| | Age Factors | 2 | 2007 | 2990 | 0.080 |
Why?
| | Auscultation | 1 | 2008 | 2 | 0.080 |
Why?
| | Cerebral Cortex | 1 | 2011 | 415 | 0.080 |
Why?
| | Kinetics | 1 | 2012 | 1623 | 0.080 |
Why?
| | Respiratory Function Tests | 1 | 2010 | 526 | 0.080 |
Why?
| | Dietary Supplements | 1 | 2012 | 468 | 0.080 |
Why?
| | Healthy Volunteers | 2 | 2019 | 194 | 0.080 |
Why?
| | Colorado | 3 | 2021 | 4178 | 0.080 |
Why?
| | Body Fat Distribution | 1 | 2007 | 45 | 0.080 |
Why?
| | Surveys and Questionnaires | 1 | 2019 | 4684 | 0.080 |
Why?
| | Phosphorylation | 1 | 2012 | 1622 | 0.080 |
Why?
| | Magnetic Resonance Imaging | 3 | 2016 | 3169 | 0.070 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2021 | 2159 | 0.070 |
Why?
| | Rats, Wistar | 4 | 2011 | 396 | 0.070 |
Why?
| | Prospective Studies | 4 | 2021 | 6443 | 0.070 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2007 | 162 | 0.070 |
Why?
| | Norepinephrine | 1 | 2007 | 212 | 0.070 |
Why?
| | Animals | 7 | 2019 | 33152 | 0.070 |
Why?
| | Dairy Products | 1 | 2005 | 31 | 0.070 |
Why?
| | Transcription, Genetic | 1 | 2012 | 1322 | 0.070 |
Why?
| | Patient Selection | 1 | 2009 | 670 | 0.070 |
Why?
| | Leptin | 3 | 2014 | 228 | 0.070 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2022 | 1237 | 0.070 |
Why?
| | Polysomnography | 2 | 2020 | 156 | 0.070 |
Why?
| | Gene Expression Regulation | 2 | 2012 | 2435 | 0.070 |
Why?
| | Photoperiod | 2 | 2019 | 55 | 0.060 |
Why?
| | Clinical Trials as Topic | 1 | 2009 | 964 | 0.060 |
Why?
| | Parasympathetic Nervous System | 1 | 2004 | 25 | 0.060 |
Why?
| | Electrocardiography, Ambulatory | 1 | 2004 | 53 | 0.060 |
Why?
| | Equipment Design | 2 | 2017 | 518 | 0.060 |
Why?
| | Long QT Syndrome | 1 | 2005 | 57 | 0.060 |
Why?
| | Statistics as Topic | 1 | 2004 | 307 | 0.060 |
Why?
| | Adiposity | 3 | 2016 | 508 | 0.060 |
Why?
| | Regression Analysis | 3 | 2018 | 984 | 0.060 |
Why?
| | Integrases | 1 | 2024 | 122 | 0.060 |
Why?
| | Electromyography | 2 | 2014 | 326 | 0.050 |
Why?
| | Hormones | 2 | 2016 | 135 | 0.050 |
Why?
| | Women's Health | 1 | 2004 | 274 | 0.050 |
Why?
| | Recurrence | 2 | 2019 | 971 | 0.050 |
Why?
| | Chronic Disease | 2 | 2005 | 1630 | 0.050 |
Why?
| | Satiation | 1 | 2021 | 24 | 0.050 |
Why?
| | Craving | 1 | 2021 | 33 | 0.050 |
Why?
| | Osteocalcin | 1 | 2021 | 35 | 0.050 |
Why?
| | Perimenopause | 1 | 2022 | 59 | 0.050 |
Why?
| | Waist Circumference | 1 | 2021 | 130 | 0.050 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2021 | 103 | 0.050 |
Why?
| | Absorptiometry, Photon | 2 | 2016 | 226 | 0.050 |
Why?
| | Uncoupling Protein 1 | 1 | 2019 | 16 | 0.040 |
Why?
| | Iodide Peroxidase | 1 | 2019 | 25 | 0.040 |
Why?
| | Rats | 4 | 2011 | 5339 | 0.040 |
Why?
| | Feces | 1 | 2021 | 392 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2022 | 746 | 0.040 |
Why?
| | Disability Evaluation | 1 | 2021 | 278 | 0.040 |
Why?
| | Bone Resorption | 1 | 2019 | 80 | 0.040 |
Why?
| | Mathematical Concepts | 1 | 2018 | 24 | 0.040 |
Why?
| | Decision Trees | 1 | 2018 | 83 | 0.040 |
Why?
| | Acidosis | 1 | 2019 | 84 | 0.040 |
Why?
| | Treatment Outcome | 3 | 2018 | 9319 | 0.040 |
Why?
| | Methanol | 1 | 2018 | 35 | 0.040 |
Why?
| | Humidity | 1 | 2018 | 45 | 0.040 |
Why?
| | Single-Blind Method | 1 | 2019 | 269 | 0.040 |
Why?
| | Solvents | 1 | 2018 | 118 | 0.040 |
Why?
| | Lower Extremity | 1 | 2021 | 334 | 0.040 |
Why?
| | Europe | 1 | 2018 | 355 | 0.040 |
Why?
| | Wrist | 1 | 2017 | 51 | 0.040 |
Why?
| | Proteomics | 1 | 2022 | 850 | 0.040 |
Why?
| | Plasma | 1 | 2018 | 194 | 0.040 |
Why?
| | Predictive Value of Tests | 1 | 2021 | 1857 | 0.040 |
Why?
| | Maximal Voluntary Ventilation | 1 | 2016 | 7 | 0.040 |
Why?
| | Materials Testing | 1 | 2018 | 359 | 0.030 |
Why?
| | Linear Models | 1 | 2018 | 817 | 0.030 |
Why?
| | Smartphone | 1 | 2016 | 67 | 0.030 |
Why?
| | Sensitivity and Specificity | 2 | 2012 | 1787 | 0.030 |
Why?
| | Machine Learning | 1 | 2018 | 321 | 0.030 |
Why?
| | Glucose Tolerance Test | 1 | 2016 | 361 | 0.030 |
Why?
| | Disease Models, Animal | 3 | 2011 | 3676 | 0.030 |
Why?
| | Nontherapeutic Human Experimentation | 1 | 2014 | 2 | 0.030 |
Why?
| | Retrospective Studies | 2 | 2023 | 12929 | 0.030 |
Why?
| | Peptides | 1 | 2019 | 879 | 0.030 |
Why?
| | Support Vector Machine | 1 | 2014 | 36 | 0.030 |
Why?
| | Risk Factors | 2 | 2020 | 8958 | 0.030 |
Why?
| | Logistic Models | 1 | 2018 | 1896 | 0.030 |
Why?
| | Bicycling | 1 | 2013 | 77 | 0.030 |
Why?
| | Drug Therapy, Combination | 1 | 2015 | 964 | 0.030 |
Why?
| | United States | 2 | 2020 | 12491 | 0.030 |
Why?
| | Anabolic Agents | 1 | 2012 | 12 | 0.030 |
Why?
| | Sleep Wake Disorders | 1 | 2015 | 238 | 0.030 |
Why?
| | DNA-Binding Proteins | 1 | 2019 | 1343 | 0.030 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2016 | 709 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2019 | 2657 | 0.020 |
Why?
| | Oxygen | 1 | 2016 | 854 | 0.020 |
Why?
| | Biomechanical Phenomena | 1 | 2014 | 683 | 0.020 |
Why?
| | Muscle Contraction | 1 | 2014 | 413 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2015 | 1937 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2018 | 2491 | 0.020 |
Why?
| | Transcription Factors | 1 | 2019 | 1567 | 0.020 |
Why?
| | Photic Stimulation | 1 | 2011 | 204 | 0.020 |
Why?
| | Geriatric Assessment | 1 | 2012 | 182 | 0.020 |
Why?
| | Reference Values | 1 | 2012 | 770 | 0.020 |
Why?
| | Glucose | 1 | 2015 | 940 | 0.020 |
Why?
| | Nutritional Requirements | 1 | 2010 | 74 | 0.020 |
Why?
| | Fourier Analysis | 1 | 2009 | 41 | 0.020 |
Why?
| | Models, Theoretical | 1 | 2014 | 554 | 0.020 |
Why?
| | Hydrostatic Pressure | 1 | 2009 | 18 | 0.020 |
Why?
| | Cognition | 1 | 2016 | 1026 | 0.020 |
Why?
| | Electric Impedance | 1 | 2009 | 99 | 0.020 |
Why?
| | Body Height | 1 | 2009 | 186 | 0.020 |
Why?
| | Veterans | 1 | 2019 | 1215 | 0.020 |
Why?
| | Physical Endurance | 1 | 2009 | 231 | 0.020 |
Why?
| | Recovery of Function | 1 | 2010 | 603 | 0.020 |
Why?
| | Carbohydrate Metabolism | 1 | 2006 | 50 | 0.020 |
Why?
| | Child | 2 | 2014 | 19033 | 0.020 |
Why?
| | Arrhythmias, Cardiac | 1 | 2005 | 277 | 0.010 |
Why?
| | Mice | 1 | 2019 | 15446 | 0.010 |
Why?
| | Mental Recall | 1 | 2003 | 180 | 0.010 |
Why?
| | Proteins | 1 | 2006 | 935 | 0.010 |
Why?
| | Severity of Illness Index | 1 | 2005 | 2659 | 0.010 |
Why?
|
|
Melanson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|